跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ERELZI
Authorized
STANDARD
ERELZI
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ed844e0b8ca7a09a
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
ed844e0b8ca7a09a
Drug Approval Canada Name
ERELZI
Product Name
ERELZI
Status
Marketed
Status Date
2017-12-08
Original Market Date
2017-12-08
Din
02462877
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
90:24.16.92
Atc Original
L04AB01 ETANERCEPT
Atc Name
l 04 ab 01
Aig Number
0151564001
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
ETANERCEPT
25 MG / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ed844e0b8ca7a09a
Type
Standard
Back to Health Canada Approvals
ERELZI - Health Canada Drug Approval Details